American Portfolios Advisors’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$74 Hold
14
﹤0.01% 3491
2022
Q2
$67 Hold
14
﹤0.01% 3492
2022
Q1
$119 Sell
14
-28
-67% -$258 ﹤0.01% 3547
2021
Q4
$503 Hold
42
﹤0.01% 3411
2021
Q3
$744 Hold
42
﹤0.01% 3348
2021
Q2
$862 Hold
42
﹤0.01% 3276
2021
Q1
$832 Hold
42
﹤0.01% 3158
2020
Q4
$780 Hold
42
﹤0.01% 2870
2020
Q3
$1.06K Hold
42
﹤0.01% 2754
2020
Q2
$1.28K Hold
42
﹤0.01% 2646
2020
Q1
$1.3K Hold
42
﹤0.01% 2504
2019
Q4
$1.91K Buy
+42
New +$1.75K ﹤0.01% 2584

Other funds holding RCEL

American Portfolios Advisors's RCEL Position: Q3 2022 in Review

American Portfolios Advisors held its Avita Medical (RCEL) position steady in Q3 2022 at 14 shares worth $74. The position accounts for ﹤0.01% of the portfolio, ranked #3491.

American Portfolios Advisors first reported a position in RCEL in Q4 2019 and has held it in 12 quarters since. The position peaked at $1.91K in Q4 2019. 48 funds tracked by Wall St. Rank hold RCEL as of Q3 2022.

  • American Portfolios Advisors held 14 shares of Avita Medical worth $74 as of Q3 2022.
  • American Portfolios Advisors left its Avita Medical share count unchanged in Q3 2022.
  • Avita Medical made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3491 holding.
  • American Portfolios Advisors first reported a position in Avita Medical in Q4 2019 and has held it in 12 quarters since.
  • American Portfolios Advisors's Avita Medical position peaked at $1.91K in Q4 2019.
  • 48 funds tracked by Wall St. Rank held Avita Medical as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.